SURAKSHA

Suraksha Diagnostic, a microcap company in the healthcare services sector, has reported its financial results for the quarter ending June 2025 on August 8, 2025. The company experienced flat financial performance, with its score declining to -2 from -1 over the past three months. On a positive note, Suraksha Diagnostic achieved its highest quarterly net sales in the last five quarters, totaling Rs 72.59 crore. The operating profit also reached a peak of Rs 23.75 crore during the same period, indicating a favorable near-term trend. Additionally, the profit before tax (PBT) grew by 23.1% compared to the average of the previous four quarters, amounting to Rs 11.56 crore. Conversely, the company faced challenges with rising interest costs, which increased by 31.07% quarter on quarter, reaching Rs 2.70 crore, the highest in the last five quarters. This rise in interest expenses has led to a decline in the operating profit to interest ratio, now at its lowest level of 8.80 times in the last five quarters, indicating a deteriorating ability to manage interest payments.